Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells
Cell,
CRISPR-Cas9 genome editing induces persistent chromosome loss in human primary T cells and engineered CAR T cells for clinical…
CRISPR-Cas9 genome editing induces persistent chromosome loss in human primary T cells and engineered CAR T cells for clinical…
T cells can be tricky to engineer with CRISPR. Find out the key considerations when editing these cells and how you can…
Researchers developed a way to genetically modify T cells using a jolt of electricity instead of a virus. This method may help…